- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02940444
Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery
October 21, 2016 updated by: Yi-Dan Lin, West China Hospital
Safety and Efficacy of Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery
Thromboembolism is an important perioperative complication in major thoracic surgery, even though current guidelines have recommended postoperative administration of heparin or LMWH for thromboprophylaxis for those high-risk patients, there are still many cases of thromboembolism.
Therefore, as the guideline itself writes, the investigators believe the rational of dose and timing of heparin in thoracic surgery are still not well established.
Therefore, the investigators aimed to conduct this randomized controlled study to explore the safety and efficacy of preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
2000
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- Recruiting
- Department of thoracic surgery, west china hospital, sichuan university
-
Contact:
- Han-Yu Deng, MD
- Phone Number: +86 18200295920
- Email: 907151184@qq.com
-
Principal Investigator:
- Yi-Dan Lin, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-75 years old without any preoperative VTEs;
- patients undergoing major thoracic surgery (including lobectomy, esophagectomy, and thymectomy).
Exclusion Criteria:
- patients with coagulation disorders: preoperative international normalized ratio (INR) > 1.5, or blood platelet count < 50x10^9/L;
- patients receiving any therapeutic anticoagulation preoperatively;
- patients with severe renal or liver dysfunction.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: case group
start heparin sodium (5000IU, BID) upon admission, and continue until discharge
|
|
|
Active Comparator: control group
start heparin sodium (5000 IU,BID) from postoperative day 1, and continue until discharge
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative bleeding volume (ml)
Time Frame: the bleeding volume (ml) during operation in the operation room for all patients
|
During the operation, the blood loss of each patient was collected and measured, and recorded by the investigators.
|
the bleeding volume (ml) during operation in the operation room for all patients
|
|
chest tube drainage volume (ml)
Time Frame: from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )
|
from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )
|
|
|
thromboembolism occurence rate (%)
Time Frame: within 30 days after surgery
|
within 30 days after surgery
|
|
|
APTT (s)
Time Frame: on postoperative day 1 for both group
|
on postoperative day 1 for both group
|
|
|
PT(s)
Time Frame: on postoperative day 1 for both group
|
on postoperative day 1 for both group
|
|
|
INR
Time Frame: on postoperative day 1 for both group
|
on postoperative day 1 for both group
|
|
|
blood platlet count(/L)
Time Frame: on postoperative day 1 for both group
|
on postoperative day 1 for both group
|
|
|
chest tube drainage duration (days)
Time Frame: from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )
|
from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
PT(s)
Time Frame: rightly upon hospital admission day
|
rightly upon hospital admission day
|
|
APTT(s)
Time Frame: rightly upon hospital admission day
|
rightly upon hospital admission day
|
|
INR
Time Frame: rightly upon hospital admission day
|
rightly upon hospital admission day
|
|
blood platlet count(/L)
Time Frame: rightly upon hospital admission day
|
rightly upon hospital admission day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (Anticipated)
June 1, 2018
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
October 17, 2016
First Submitted That Met QC Criteria
October 20, 2016
First Posted (Estimate)
October 21, 2016
Study Record Updates
Last Update Posted (Estimate)
October 24, 2016
Last Update Submitted That Met QC Criteria
October 21, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WCH-20160601
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.